Stockscreener 앱 받기
154.38
0.85%
-1.33
시장 영업 전:
154.40
0.02
+0.01%
전일 마감가:
$155.71
열려 있는:
$155.91
하루 거래량:
385.57K
Relative Volume:
1.07
시가총액:
$4.47B
수익:
$290.51M
순이익/손실:
$89.16M
주가수익비율:
51.63
EPS:
2.99
순현금흐름:
$119.18M
1주 성능:
+9.33%
1개월 성능:
+2.74%
6개월 성능:
-13.94%
1년 성능:
-20.53%
1일 변동 폭
$151.88
$157.96
1주일 범위
$136.73
$157.96
52주 변동 폭
$122.80
$207.84
Krystal Biotech Inc Stock (KRYS) Company Profile
명칭
Krystal Biotech Inc
전화
(412) 586-5830
주소
2100 WHARTON STREET, PITTSBURGH, PA
KRYS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
KRYS
Krystal Biotech Inc
|
154.38 | 4.51B | 290.51M | 89.16M | 119.18M | 2.99 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.36 | 100.82B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
461.24 | 60.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
575.06 | 60.69B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
752.32 | 46.32B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
327.20 | 36.58B | 3.81B | -644.79M | -669.77M | -6.24 |
Krystal Biotech Inc Stock (KRYS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-05 | 개시 | Jefferies | Buy |
| 2024-08-06 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2023-11-20 | 개시 | Goldman | Buy |
| 2023-10-24 | 개시 | Cantor Fitzgerald | Overweight |
| 2023-10-12 | 개시 | Citigroup | Buy |
| 2023-09-07 | 개시 | Berenberg | Buy |
| 2023-04-18 | 개시 | Stifel | Buy |
| 2023-02-28 | 업그레이드 | Goldman | Neutral → Buy |
| 2022-08-25 | 다운그레이드 | Goldman | Buy → Neutral |
| 2022-01-18 | 개시 | BofA Securities | Buy |
| 2021-07-20 | 업그레이드 | Goldman | Neutral → Buy |
| 2020-09-18 | 개시 | B. Riley FBR | Buy |
| 2020-06-04 | 개시 | Evercore ISI | Outperform |
| 2019-09-24 | 개시 | Goldman | Neutral |
| 2019-08-06 | 재확인 | H.C. Wainwright | Buy |
| 2019-06-24 | 재확인 | Chardan Capital Markets | Buy |
| 2019-06-24 | 재확인 | H.C. Wainwright | Buy |
| 2019-05-30 | 개시 | Guggenheim | Buy |
| 2018-09-11 | 개시 | Cantor Fitzgerald | Overweight |
모두보기
Krystal Biotech Inc 주식(KRYS)의 최신 뉴스
Hedge Fund Bets: What is the PEG ratio of Krystal Biotech IncJuly 2025 Rallies & Smart Allocation Stock Reports - خودرو بانک
Dystrophic Epidermolysis Bullosa Pipeline Insight 2025: - openPR.com
Fred Alger Management LLC Buys New Position in Krystal Biotech, Inc. $KRYS - MarketBeat
Krystal Biotech (NASDAQ:KRYS) Receives "Buy" Rating from HC Wainwright - MarketBeat
Krystal Biotech Stock Up on FDA Nod to Vyjuvek Label Update - Yahoo Finance
Aug Intraday: What is Krystal Biotech Incs market positionJuly 2025 News Drivers & Stepwise Trade Execution Plans - خودرو بانک
3 Promising Growth Companies With Insider Ownership Up To 18% - simplywall.st
IPO Launch: Can Krystal Biotech Inc sustain earnings growth2025 Technical Overview & Free Real-Time Volume Trigger Notifications - خودرو بانک
Exit Recap: Should you buy the dip on Krystal Biotech IncJuly 2025 Gainers & Community Verified Trade Signals - خودرو بانک
Krystal Biotech stock maintains Buy rating at TD Cowen on Vyjuvek label update - Investing.com Canada
What are Krystal Biotech Inc.’s growth leversEarnings Overview Report & AI Based Buy/Sell Signal Reports - خودرو بانک
FDA Expands Krystal Biotech Vyjuvek's Label Allowing Newborns Access To Gene Therapy For Blistering Skin - AOL.com
Is Krystal Biotech Inc. stock showing strong momentumWeekly Loss Report & AI Enhanced Market Trend Forecasts - خودرو بانک
Krystal Biotech stock jumps after FDA expands VYJUVEK label By Investing.com - Investing.com Canada
Krystal Biotech stock jumps after FDA expands VYJUVEK label - Investing.com
Krystal Biotech (KRYS) Buy Rating Reiterated by HC Wainwright & Co. | KRYS Stock News - GuruFocus
Why Is Krystal Biotech Stock Surging Monday?Krystal Biotech (NASDAQ:KRYS) - Benzinga
Krystal Biotech gets expanded FDA approval for Vyjuvek (KRYS:NASDAQ) - Seeking Alpha
FDA approves expanded label for Krystal Biotech’s DEB treatment By Investing.com - Investing.com Canada
Does TimesSquare's Exit After Weaker Results Signal a Shift in Krystal Biotech's (KRYS) Growth Priorities? - Sahm
Krystal Biotech Announces FDA Approval of Updated VYJUVEK® Label - The Manila Times
Krystal Biotech Announces FDA Approval of VYJUVEK Label Update to Include DEB Patients from Birth and Allow Self-Application - Quiver Quantitative
Krystal Biotech announces FDA approval of updated Vyjuvek label - MarketScreener
Major DEB Treatment Breakthrough: VYJUVEK Now Available From Birth, Patients Can Self-Administer at Home - Stock Titan
S Squared Technology LLC Raises Holdings in Krystal Biotech, Inc. $KRYS - MarketBeat
UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC Acquires 365,304 Shares of Krystal Biotech, Inc. $KRYS - MarketBeat
EP Wealth Advisors LLC Acquires Shares of 2,621 Krystal Biotech, Inc. $KRYS - MarketBeat
Krystal Biotech, Inc. (NASDAQ:KRYS) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
TSCM U.S. Small Cap Growth Strategy Reduced Its Position in Krystal Biotech (KRYS) - Insider Monkey
Eschler Asset Management LLP Purchases New Stake in Krystal Biotech, Inc. $KRYS - MarketBeat
Trexquant Investment LP Invests $2.37 Million in Krystal Biotech, Inc. $KRYS - MarketBeat
Aug Patterns: Is Krystal Biotech Inc. impacted by rising ratesJuly 2025 Review & Verified Trade Idea Suggestions - Lancaster City Council
Watch for Trend Continuation in Krystal Biotech Inc. Next WeekRate Cut & Growth Oriented Trading Recommendations - beatles.ru
Redmile Group LLC Has $133 Million Stock Position in Krystal Biotech, Inc. $KRYS - MarketBeat
What recovery options are there for Krystal Biotech Inc.2025 Trade Ideas & Free AI Powered Buy and Sell Recommendations - Newser
What is the earnings history of Krystal Biotech Inc.Dollar Strength & Daily Growth Stock Investment Tips - خودرو بانک
Aug PreEarnings: Is Krystal Biotech Inc. stock undervalued right nowJuly 2025 Setups & Risk Controlled Swing Trade Alerts - خودرو بانک
What are Krystal Biotech Inc.’s recent SEC filings showing2025 Geopolitical Influence & AI Driven Price Forecasts - خودرو بانک
Braidwell LP Raises Stake in Krystal Biotech, Inc. $KRYS - MarketBeat
When is the best time to exit Krystal Biotech Inc.Earnings Recap Summary & AI Enhanced Execution Alerts - Newser
How do insiders feel about Krystal Biotech Inc.Fed Meeting & Weekly Return Optimization Alerts - خودرو بانک
What’s the MACD signal for Krystal Biotech Inc.Earnings Summary Report & Real-Time Buy Zone Alerts - خودرو بانک
Has Krystal Biotech Inc. found a price floorJuly 2025 Macro Moves & AI Forecasted Stock Moves - Newser
What is Krystal Biotech Inc. s debt to equity ratio2025 Bull vs Bear & Community Consensus Trade Signals - خودرو بانک
Will Krystal Biotech Inc. stock recover after recent dropPortfolio Value Report & Low Drawdown Trading Strategies - Newser
Understanding Krystal Biotech Inc.’s price movement2025 Dividend Review & Verified Entry Point Signals - Newser
Regression analysis insights on Krystal Biotech Inc. performanceJuly 2025 Volume & Smart Allocation Stock Reports - Newser
Jump Financial LLC Invests $538,000 in Krystal Biotech, Inc. $KRYS - MarketBeat
Key metrics from Krystal Biotech Inc.’s quarterly data2025 Growth vs Value & Long-Term Growth Stock Strategies - Newser
Using data models to predict Krystal Biotech Inc. stock movementPortfolio Gains Summary & Daily Price Action Insights - Newser
Using flow based indicators on Krystal Biotech Inc.Gold Moves & Fast Entry Momentum Trade Alerts - Newser
Krystal Biotech Inc (KRYS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.77%
1.53%
자본화:
|
볼륨(24시간):